Literature DB >> 18442624

Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

Michiaki Fukui1, Muhei Tanaka, Emi Shiraishi, Ichiko Harusato, Hiroko Hosoda, Mai Asano, Mayuko Kadono, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura.   

Abstract

Hyperuricemia has been reported to be associated with increased risk of renal insufficiency as well as cardiovascular events. The aim of this study was to evaluate the relationships between serum uric acid concentration and degree of urinary albumin excretion as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. Serum uric acid concentrations were measured in 343 men with type 2 diabetes mellitus. We then evaluated relationships of serum uric acid concentrations to degree of urinary albumin excretion as well as to major cardiovascular risk factors, including age, blood pressure, serum lipid concentration, and glycemic control (hemoglobin A1c). The relationships between serum uric acid concentration and pulse wave velocity or ankle-brachial index (n=236) and between serum uric acid concentration and carotid intima-media thickness or plaque score (n=125) were investigated additionally in a subgroup of patients. Serum uric acid concentration correlated positively with logarithm of urinary albumin excretion (r=0.302, P<.0001). Positive correlation was found between serum uric acid concentration and intima-media thickness (r=0.233, P=.0087), whereas inverse correlation was found between serum uric acid concentration and ankle-brachial index (r=-0.150, P=.0207). Multiple regression analysis demonstrated that serum uric acid concentration (beta=.281, P<.0001), duration of diabetes (beta=.253, P<.0001), hemoglobin A1c (beta=.166, P=.0034), serum triglyceride concentration (beta=.125, P=.0472), and systolic blood pressure (beta=.275, P=.0013) were independent determinants of logarithm of urinary albumin excretion. In conclusion, serum uric acid concentration is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442624     DOI: 10.1016/j.metabol.2007.12.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  39 in total

1.  N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Takafumi Senmaru; Michiaki Fukui; Muhei Tanaka; Kazumi Sakabe; Emi Ushigome; Mai Asano; Masahiro Yamazaki; Goji Hasegawa; Naoto Nakamura
Journal:  Heart Vessels       Date:  2012-01-11       Impact factor: 2.037

2.  Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.

Authors:  J Zhang; G Xiang; L Xiang; H Sun
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

3.  Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus.

Authors:  Emin Murat Akbas; Aysu Timuroglu; Adalet Ozcicek; Fatih Ozcicek; Levent Demirtas; Adem Gungor; Nergis Akbas
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

5.  Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography.

Authors:  Rada Gancheva; Atanas Kundurdjiev; Mariana Ivanova; Todor Kundurzhiev; Zlatimir Kolarov
Journal:  Rheumatol Int       Date:  2016-08-30       Impact factor: 2.631

Review 6.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

7.  The effect of dapagliflozin on renal function in patients with type 2 diabetes.

Authors:  Donald Elliott Kohan; Paola Fioretto; Kristina Johnsson; Shamik Parikh; Agata Ptaszynska; Lisa Ying
Journal:  J Nephrol       Date:  2016-02-19       Impact factor: 3.902

Review 8.  Hyperuricemia and renal risk.

Authors:  Francesca Viazzi; Giovanna Leoncini; Elena Ratto; Roberto Pontremoli
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-31

9.  Losartan alleviates hyperuricemia-induced atherosclerosis in a rabbit model.

Authors:  Hongchao Zheng; Ning Li; Yueyou Ding; Peizhi Miao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients.

Authors:  Giacomo Zoppini; Giovanni Targher; Carlo Negri; Vincenzo Stoico; Fabrizia Perrone; Michele Muggeo; Enzo Bonora
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.